Peruvian scientist is awarded for developing new varieties of plants using nuclear energy

Peruvian researcher Luz Rayda Gómez-Pando has been awarded for her work in the development of new varieties of plants using nuclear energy. The International Atomic Energy Agency (IAEA) and the Food and Agriculture Organization of the United Nations (FAO) awarded her the Prize to Women in Plant Breeding by Induction of Mutations.

SIGHT: New Concytec rules for scientists: “Now the researcher has to show that he has activity”

“There are very few researchers who do genetic improvement of plants in our country. We need more professionals to develop to face climate change ”, the scientist told the Andean Agency.

It is the second time that Luz Rayda Gómez-Pando, who is a senior professor in the Phytotechnics Department of the Faculty of Agronomy and head of the Cereals and Native Grains Program of the La Molina National Agrarian University (UNALM), receives this important award.

SIGHT: Kipi, the robot created in Vraem that speaks Quechua with schoolchildren from Huancavelica

Thanks to her knowledge in nuclear energy, the researcher has developed varieties of kiwicha, barley, wheat, among other plants, since the 1980s. And in that work he has contributed directly to the farmers of the central and southern highlands of the country.

Shortly after leaving her professional activity, the researcher highlights that One of her legacies – she affirms – is having contributed to the creation of the UNALM Germplasm Bank, one of the most complete in the country.

• COVID-19 | Sanofi to suspend development of its messenger RNA vaccine
• Pfizer Starts Human Trials of Messenger RNA Flu Vaccine
• Delta Plus variant of the coronavirus: More contagious and resistant to vaccines?
• COVID-19 | Patients who come to the ICU are mostly men and have more antibodies
• COVID-19 | Results of the Sinopharm clinical trial conducted in Peru will be “very soon”
• Sinopharm will be accepted to travel to the US: reasons to trust the Chinese vaccine
• What are “rogue” antibodies and what do they have to do with severe COVID-19?
• What will the third year of the pandemic be like ?, by Elmer Huerta
• COVID-19 | New Chinese vaccine is 79% effective against Delta variant
• COVID-19 May Look Like a Cold in the Future, AstraZeneca Developer Says
• Delta variant of COVID-19 is now predominant in Peru: five things you should know
• COVID-19 | Europe will decide in October whether to authorize Pfizer’s booster dose
• Sinopharm will be accepted to travel to the US: reasons to trust the Chinese vaccine
• COVID-19 | How close are we to the end of the pandemic?
• Who will the third dose of Pfizer reach in the US?
• COVID-19 infection may precede Guillain-Barré syndrome in rare cases
• COVID-19 | “It is a harm to public health for someone to apply more than two doses on their own”
• COVID-19 | Six billion doses of vaccines have been administered worldwide
• They find a virus very similar to that of COVID-19 in bats of Laos
• Brazil and Argentina will produce mRNA vaccines against COVID-19 for the region, PAHO announces
• Convalescent Plasma: Does This Therapy Work To Treat COVID-19 Patients?

Follow us on twitter:

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);

.

Deshawn